Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study

被引:4
作者
Xiao, Yue [1 ]
Chen, Yanfei [1 ]
Huang, Ruijian [1 ]
Jiang, Feng [1 ]
Zhou, Jifang [1 ]
Yang, Tianchi [2 ]
机构
[1] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China
[2] Ningbo Municipal Ctr Dis Control & Prevent, Inst TB Prevent & Control, 237 Yongfeng Rd, Ningbo, Zhejiang, Peoples R China
关键词
Machine learning; Logistic regression; Tuberculosis; Drug-induced liver injury; Retrospective study; HEALTH; HEPATOTOXICITY; GUIDELINES;
D O I
10.1186/s12874-024-02214-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The objective of this research was to create and validate an interpretable prediction model for drug-induced liver injury (DILI) during tuberculosis (TB) treatment.Methods A dataset of TB patients from Ningbo City was used to develop models employing the eXtreme Gradient Boosting (XGBoost), random forest (RF), and the least absolute shrinkage and selection operator (LASSO) logistic algorithms. The model's performance was evaluated through various metrics, including the area under the receiver operating characteristic curve (AUROC) and the area under the precision recall curve (AUPR) alongside the decision curve. The Shapley Additive exPlanations (SHAP) method was used to interpret the variable contributions of the superior model.Results A total of 7,071 TB patients were identified from the regional healthcare dataset. The study cohort consisted of individuals with a median age of 47 years, 68.0% of whom were male, and 16.3% developed DILI. We utilized part of the high dimensional propensity score (HDPS) method to identify relevant variables and obtained a total of 424 variables. From these, 37 variables were selected for inclusion in a logistic model using LASSO. The dataset was then split into training and validation sets according to a 7:3 ratio. In the validation dataset, the XGBoost model displayed improved overall performance, with an AUROC of 0.89, an AUPR of 0.75, an F1 score of 0.57, and a Brier score of 0.07. Both SHAP analysis and XGBoost model highlighted the contribution of baseline liver-related ailments such as DILI, drug-induced hepatitis (DIH), and fatty liver disease (FLD). Age, alanine transaminase (ALT), and total bilirubin (Tbil) were also linked to DILI status.Conclusion XGBoost demonstrates improved predictive performance compared to RF and LASSO logistic in this study. Moreover, the introduction of the SHAP method enhances the clinical understanding and potential application of the model. For further research, external validation and more detailed feature integration are necessary.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system
    Mani, Selvin Sundar Raj
    Iyyadurai, Ramya
    Mishra, Ajay Kumar
    Manjunath, Krishna
    Prasad, Jasmin
    Lakshmanan, Jeyaseelan
    Yadav, Bijesh
    Reginald, Alex
    Jasmine, Sudha
    Hansdak, Samuel George
    Zachariah, Anand
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2021, 10 (02) : 116 - +
  • [32] Predicting drug-induced liver injury: The importance of data curation
    Kotsampasakou, Eleni
    Montanari, Floriane
    Ecker, Gerhard F.
    TOXICOLOGY, 2017, 389 : 139 - 145
  • [33] Deep Learning Algorithm Based on Molecular Fingerprint for Prediction of Drug-Induced Liver Injury
    Yang, Qiong
    Zhang, Shuwei
    Li, Yan
    TOXICOLOGY, 2024, 502
  • [34] Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: a multicenter study
    Hou, Fei
    Zhu, Yun
    Zhao, Hongbo
    Cai, Haolin
    Wang, Yinghui
    Peng, Xiaoqi
    Lu, Lin
    He, Rongli
    Hou, Yan
    Li, Zhenhui
    Chen, Ting
    ECLINICALMEDICINE, 2024, 77
  • [35] Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury
    Devarbhavi, Harshad
    Singh, Rajvir
    Patil, Mallikarjun
    Sheth, Keyur
    Adarsh, Channagiri Krishnamurthy
    Balaraju, Girisha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 161 - 167
  • [36] Risk Prediction of Liver Injury in Pediatric Tuberculosis Treatment: Development of an Automated Machine Learning Model
    Zeng, Ying
    Lu, Hong
    Li, Sen
    Shi, Qun-Zhi
    Liu, Lin
    Gong, Yong-Qing
    Yan, Pan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 239 - 250
  • [37] Drug-Induced Liver Injury and Drug Development: Industry Perspective
    Regev, Arie
    SEMINARS IN LIVER DISEASE, 2014, 34 (02) : 227 - 239
  • [38] Early sepsis mortality prediction model based on interpretable machine learning approach: development and validation study
    Wang, Yiping
    Gao, Zhihong
    Zhang, Yang
    Lu, Zhongqiu
    Sun, Fangyuan
    INTERNAL AND EMERGENCY MEDICINE, 2024, : 909 - 918
  • [39] Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort
    Moosa, Muhammed Shiraz
    Maartens, Gary
    Gunter, Hannah
    Allie, Shaazia
    Chughlay, Mohamed F.
    Setshedi, Mashiko
    Wasserman, Sean
    Stead, David F.
    Cohen, Karen
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2022, 23 (01) : 1 - 5
  • [40] Artificial Intelligence and Machine Learning Models for Predicting Drug-Induced Kidney Injury in Small Molecules
    Rao, Mohan
    Nassiri, Vahid
    Srivastava, Sanjay
    Yang, Amy
    Brar, Satjit
    Mcduffie, Eric
    Sachs, Clifford
    PHARMACEUTICALS, 2024, 17 (11)